Mattel Children's Hospital UCLA launches new nanopediatrics program
UCLA Mattel Children's Hospital will announce the new Mattel UCLA NanoPediatrics Program at this half-day symposium. Believed to be the world's first nanotechnology program dedicated solely to pediatric patients, the program will explore the future of personalized medicine for children, including the opportunities and risks involved.
Symposium speakers will include:
Dr. Edward McCabePhysician-in-chief of UCLA Mattel Children's HospitalTopic: "Why nanopediatrics? Because children are not small adults"Dr. Kathleen SakamotoUCLA professor and chief of pediatric hematology and oncologyTopic: "Protacs: Chimeric molecules that target proteins for ubiquitination and degradation"Andre NelDirector of the UC Lead Campus for Nanotoxicology Research and TrainingTopic: "The use of nanoparticles for diagnosing and imaging in children"Dr. Chris DennyUCLA professor of hematology and oncologyTopic: "Targeting pediatric cancers using polymerized liposomal nanoparticles"Leonard RomeInterim director of the California NanoSystems Institute at UCLATopic: "Engineering vault nanocapsules as therapeutic delivery vehicles"
8 a.m.noon, Friday, Oct. 17
- 89 a.m.: Tamkin Auditorium (B130) Ronald Reagan UCLA Medical Center (UCLA campus)
- 9:30 a.m.noon: CNSI Auditorium, California NanoSystems Institute at UCLA (UCLA campus)
The Mattel UCLA NanoPediatrics Program was created thanks to a $1.8 million gift from Mattel Inc. The program will support a nanopediatrics research core and pilot funding for projects that will potentially enable investigators to obtain grants from the National Institutes of Health. The program will partner with the California NanoSystems Institute (CNSI), a research center at UCLA established to encourage university collaboration with industry and enable the rapid commercialization of discoveries in nanosystems.
Amy Albin, UCLA Health Sciences Media Relations, 310-794-8672
Call media contact to arrange parking.